Conference Coverage
Conference Coverage
Select biologics for dose escalation in psoriasis
Conference Coverage
Secukinumab showed sustained efficacy in psoriasis
Key clinical point: Psoriasis patients’ initial strong clinical response to the interleukin-17A inhibitor secukinumab is sustained through 52...
Conference Coverage
In psoriasis, is pushing for PASI 90 really worthwhile?
Key clinical point: Psoriasis patients who obtain a PASI 90 response report the quality of life burden imposed by the disease is lifted a full...
Conference Coverage
Minimal disease activity in psoriatic arthritis is a realistic target
Conference Coverage
Jury still out on effect of systemic psoriasis meds on MI risk
Conference Coverage
Psoriasis patients post above-average cancer rates
Key clinical point: Rates of malignancy were higher among patients with psoriasis than in the general population. Major finding: The 5-year...
Conference Coverage
Think methotrexate for juvenile localized scleroderma
Conference Coverage
Infliximab may carry a higher infection rate in psoriasis patients
Key clinical point: The risk of being hospitalized for an infectious event was higher with exposure to infliximab.Major finding: The incidence of...
Conference Coverage
VIDEO: Stress and inflammatory skin diseases – Does the science prove a link?
Conference Coverage
Psoriasiform lesions in Kawasaki disease may spell trouble
Key clinical point: Further study will need to determine if treatment, time to diagnosis, or other factors influence the association between...